Response rate estimation in single-stage basket trials: A comparison of estimators that allow for borrowing across cohorts

Antonios Daletzakis; Rutger van den Bor; Vincent van der Noort; Kit CB Roes

Home/Archive/arXiv

arXiv · 2502.07639

Response rate estimation in single-stage basket trials: A comparison of estimators that allow for borrowing across cohorts

Antonios Daletzakis·Rutger van den Bor·Vincent van der Noort·Kit CB Roes

View original source ↗Read source document ↗Export metadata ↓

Abstract

Therapeutic advancements in oncology have shifted towards targeted therapy based on genomic aberrations. This necessitates innovative statistical approaches in clinical trials, particularly in master protocol studies. Basket trials, a type of master protocol, evaluate a single treatment across cohorts sharing a genomic aberration but differing in tumor histology. While offering operational advantages, basket trial analysis presents statistical inference challenges. These trials help determine for which tumor histology the treatment is promising enough to advance to confirmatory evaluation and often use Bayesian designs to support decisions. Beyond decision-making, estimating cohort-specific response rates is crucial for designing subsequent trials. This study compares seven Bayesian estimation methods for basket trials with binary outcomes against the (frequentist) sample proportion estimate through simulations. The goal is to estimate cohort-specific response rates, focusing on bias, mean squared error, and information borrowing. Various scenarios are examined, including homogeneous, heterogeneous, and clustered response rates across cohorts. Results show trade-offs in bias and precision, highlighting the importance of method selection. Berry's method performs best with limited heterogeneity. No clear winner emerges in general cases, with performance affected by shrinkage, bias, and the choice of priors and tuning parameters. Challenges include computational complexity, parameter tuning, and the lack of clear guidance on selection. Researchers should consider these factors when designing and analyzing basket trials.

Explore related subjects

stat.AP

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Antonios Daletzakis, Rutger van den Bor, Vincent van der Noort, Kit CB Roes. 2025-02-11. Response rate estimation in single-stage basket trials: A comparison of estimators that allow for borrowing across cohorts. https://arxiv.org/abs/2502.07639

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

arXiv2026

Online activity prediction via generalized Indian buffet process models

Online A/B tests are the standard tool for data-driven decision-making at scale. Among the design choices with the largest impact on statistical power is the triggering mechanism: how many users to expose and for how long. This often requires forecasting user engagement, i.e., whether enough users will trigger, and when a target participation level will be reached, from limited pilot data. We introduce a Bayesian nonparametric model for predicting both new-user counts and total triggers, accommodating the heavy-tailed engagement patterns typical of web experiments. All predictive quantities can be computed without intensive numerical procedures such as Markov chain Monte Carlo (MCMC) or variational inference. We evaluate on three public datasets (over 450 public benchmark evaluations) and a proprietary benchmark drawn from 759 production A/B tests comprising 1,774 arms. Across the benchmark analyses, our models are competitive and frequently improve accuracy in forecasting new users, total triggers, and time to reach a target sample size compared with state-of-the-art competitors, especially when only a few pilot days are observed.

stat.AP↗

arXiv2026

Spending Scarce Confirmatory PET Measurements: Target-Aligned Validation in A4/LEARN

Anti-amyloid therapies and blood-based biomarkers are changing Alzheimer disease workups into a two-stage measurement workflow: screen broadly with cheaper information, then spend scarce confirmatory amyloid measurements where they support the decision that will be reported. Amyloid positron-emission tomography (PET) remains one such protocol measurement for amyloid burden, but PET slots, trial budgets, and payer-facing evidence packages are finite. This paper asks a deliberately operational question: when is simple transparent PET validation enough, and when is a fitted residual-uncertainty score worth the added complexity? For a weighted protocol target, the first-order value of validating subject i is the product of target influence and residual protocol uncertainty. Generic uncertainty sampling uses only the second factor and can spend PET measurements on subjects that are hard to predict but weak for the scientific, clinical, or commercial claim. We apply this rule to the A4/LEARN PET archive, treating observed PET as a design laboratory for scarce-confirmation studies. For the primary APOE4 carrier versus non-carrier contrast in Centiloid 24-or-higher PET positivity, simple APOE4-balanced validation recovers nearly all of the target-specific gain: at PET budget 200, the confidence-interval width ratio relative to random validation is 0.923 for APOE4 balancing and 0.914 for target-specific scoring, while generic uncertainty sampling is 0.980. Other targets behave differently: target-specific scoring gives larger gains for an age-slope analysis and for cutoff-indexed PET positivity. The practical message is simple: spend scarce protocol measurements according to the claim being validated, not only according to prediction uncertainty.

stat.AP↗

arXiv2026

Identifying Damage Pathways Linking Sequence Composition to Storage Failure in DNA Data Storage via High-Dimensional Mediation Analysis

DNA data storage offers extraordinary information density and long-term durability, but its reliability is limited by sequence-dependent errors introduced during synthesis and accumulated during storage. It remains unclear how sequence composition is associated with storage failure through specific molecular damage components. We develop a high-dimensional semiparametric mediation framework for survival outcomes. GC content is treated as the exposure, a high-dimensional baseline damage spectrum (a vector of per-read damage counts stratified by trinucleotide context and error type) as the mediator, and storage-quality failure as the outcome. Nonlinear covariate effects in both the mediator and survival models are approximated using deep neural networks. A three-step procedure combining product-of-coefficients screening, Smoothly Clipped Absolute Deviation (SCAD) penalized estimation, and joint significance testing is developed for mediator selection and inference. Applied to an aging experiment on electrochemically synthesized DNA, the method identifies 14 significant mediators, all corresponding to single-base deletions, with estimated mediated effects concentrated in trinucleotide contexts ending in C. These results reveal deletion-type damage as a major pathway linking sequence composition to reduced archival reliability and suggest candidate sequence features for future optimization and error-control strategies. The proposed framework thus offers a mechanism-oriented statistical approach for understanding and improving the reliability of DNA data storage.

stat.AP↗